(Q43583145)

English

A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma

scientific article published in February 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

9

object named as

Koike T

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Endo T

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sakai T

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Fujimoto K

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Yamamoto S

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Takashima H

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Haseyama Y

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Nishio M

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Koizumi K

8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sawada K

10

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

1 February 2001

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

433-436

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survey in Japan, 1987-1991.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

21 January 2018

Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

21 January 2018

A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

21 January 2018

Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

21 January 2018

The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

21 January 2018

Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following standard-dose combination chemotherapy with etoposide, ifosfamide, and cisplatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

21 January 2018

Effective high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation in a patient with the aggressive form of cytophagic histiocytic panniculitis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

21 January 2018

Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

21 January 2018

Hepatitis B reactivation after lamivudine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

21 January 2018

Hepatitis B infection in patients with lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

21 January 2018

A pilot study of a response oriented chemotherapeutic regimen combined with autologous peripheral blood progenitor cell transplantation in aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of delayed granulocyte colony-stimulating factor after full dose CHOP therapy in non-Hodgkin's lymphoma: a pilot study for a leukocyte count oriented regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of severe hepatic injury by interferon-alpha in chronic active hepatitis lacking HBeAg (mutant strain) in a patient with malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702804

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1702804

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43583145&oldid=2206140439"